Not worth it
App is not that great. Hard to find things. Easier to go online than to use this. A lot of things are DSM 4 vs 5.
Downloads
Umsatz
Beschreibung
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
The revised 14th edition of the essential reference for the prescribing of drugs for patients with mental health disorders. Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health.
The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems?
The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe & effective prescribing of psychotropic agents. Covering both common & complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum & maximum doses, adverse effects, switching medications, prescribing for special patient groups & more. Each clear & concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based.
The 14th edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions & all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand & Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry:
* Provides succinct coverage of drug treatment of psychiatric conditions & formulating prescribing policy in mental health
* Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression & anxiety, borderline personality, eating disorders & many others
* Provides advice on prescribing for children & adolescents, older people, pregnant women & other special patient groups
* Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses & dopamine super-sensitivity
* Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco & caffeine, and treating patients with comorbid physical conditions
* Whether in the doctor's office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, 14th Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses & other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy & nursing.
Content licensed from printed edition ISBN 10:1119772222 & ISBN 13:9781119772224
SUBSCRIPTION:
Please purchase a yearly auto-renewing subscription to receive content access & available updates.
Yearly auto-renewing payments- $42.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: [email protected] or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Author(s): David M. Taylor, Thomas R. E. Barnes, Allan H. Young
Publisher: John Wiley & Son Inc. and its affiliates
Ausblenden
Mehr anzeigen...
The revised 14th edition of the essential reference for the prescribing of drugs for patients with mental health disorders. Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health.
The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems?
The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe & effective prescribing of psychotropic agents. Covering both common & complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum & maximum doses, adverse effects, switching medications, prescribing for special patient groups & more. Each clear & concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based.
The 14th edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions & all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand & Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry:
* Provides succinct coverage of drug treatment of psychiatric conditions & formulating prescribing policy in mental health
* Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression & anxiety, borderline personality, eating disorders & many others
* Provides advice on prescribing for children & adolescents, older people, pregnant women & other special patient groups
* Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses & dopamine super-sensitivity
* Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco & caffeine, and treating patients with comorbid physical conditions
* Whether in the doctor's office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, 14th Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses & other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy & nursing.
Content licensed from printed edition ISBN 10:1119772222 & ISBN 13:9781119772224
SUBSCRIPTION:
Please purchase a yearly auto-renewing subscription to receive content access & available updates.
Yearly auto-renewing payments- $42.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: [email protected] or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Author(s): David M. Taylor, Thomas R. E. Barnes, Allan H. Young
Publisher: John Wiley & Son Inc. and its affiliates
In-App-Käufe
- Psychiatry Pres. Guide 3M Sub
- €39.99
- Psychiatry Pres. Guide 6M Sub
- €59.99
- 15%off-Psych Pres Guide 1Y Sub
- €79.99
- 20%off-Psych Pres Guide 1Y Sub
- €69.99
- 25%off-Psych Pres Guide 1Y Sub
- €69.99
- Maudsley Pres Guide-Psychiatry
- €79.99
- Psych. Pres. Guide 1/Y Sub off
- €67.99
- Psychiatry Pres. Guide 1/Y Sub
- €80.99
Screenshots
Maudsley Prescribing Guideline Häufige Fragen
-
Ist Maudsley Prescribing Guideline kostenlos?
Ja, Maudsley Prescribing Guideline ist kostenlos herunterzuladen, enthält jedoch In-App-Käufe oder Abonnements.
-
Ist Maudsley Prescribing Guideline seriös?
Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.
Danke für die Stimme -
Wie viel kostet Maudsley Prescribing Guideline?
Maudsley Prescribing Guideline bietet mehrere In-App-Käufe/Abonnements, der durchschnittliche In-App-Preis beträgt €68.62.
-
Wie hoch ist der Umsatz von Maudsley Prescribing Guideline?
Um geschätzte Einnahmen der Maudsley Prescribing Guideline-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.
Benutzerbewertung
Die App ist in Griechenland noch nicht bewertet.
Bewertungsverlauf
Maudsley Prescribing Guideline Bewertungen
Store-Rankings
Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
|
Diagramm
|
Kategorie
|
Rang
|
|---|---|---|
|
Top Umsatz
|
|
32
|
|
Top Umsatz
|
|
62
|
|
Top Umsatz
|
|
79
|
|
Top Umsatz
|
|
80
|
|
Top Umsatz
|
|
89
|
Maudsley Prescribing Guideline Konkurrenten
| Name | Downloads (30d) | Monatlicher Umsatz | Rezensionen | Bewertungen | Letzte Veröffentlichung | |
|---|---|---|---|---|---|---|
Waco Guide- Psychopharmacology
Clinical Decision Support
|
Freischalten
|
Freischalten
|
0
|
|
vor 8 Monaten | |
NEI Prescribe
|
Freischalten
|
Freischalten
|
0
|
|
vor 1 Monat | |
NEI Learn
|
Freischalten
|
Freischalten
|
0
|
|
vor 7 Monaten | |
DSM-5-TR® Diagnosis Handbook
Differential DDx Text Revision
|
Freischalten
|
Freischalten
|
0
|
|
vor 3 Monaten | |
NbN3
|
Freischalten
|
Freischalten
|
0
|
|
vor 10 Monaten | |
Columbia Psychiatry Pathways
The Depression Algorithm
|
Freischalten
|
Freischalten
|
0
|
|
vor 1 Jahr | |
SMI Adviser
|
Freischalten
|
Freischalten
|
0
|
|
vor 7 Monaten | |
Psychiatric Disorders
from @Point of Care™
|
Freischalten
|
Freischalten
|
0
|
|
vor 4 Monaten | |
APA eBooks
|
Freischalten
|
Freischalten
|
0
|
|
vor 2 Jahren | |
Case Files Psychiatry, 6e
Sixty high-yield cases - Lange
|
Freischalten
|
Freischalten
|
0
|
|
vor 1 Monat |
Maudsley Prescribing Guideline Installationen
Letzte 30 Tage
Maudsley Prescribing Guideline Umsatz
Letzte 30 TageMaudsley Prescribing Guideline Einnahmen und Downloads
Gewinnen Sie wertvolle Einblicke in die Leistung von Maudsley Prescribing Guideline mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
App-Informationen
- Kategorie
- Medical
- Herausgeber
- Skyscape Medpresso
- Sprachen
- English
- Letzte Veröffentlichung
- 5.4.10 (vor 3 Monaten )
- Veröffentlicht am
- Jan 20, 2021 (vor 3 Jahren )
- Auch verfügbar in
- Vereinigte Staaten , Vereinigtes Königreich , Australien , Saudi-Arabien , Kanada , Italien , Portugal , Brasilien , Mexiko , Chile , Indien , Südafrika , Schweden , Frankreich , Finnland , Ägypten , Dänemark , Deutschland , Tschechien , Belgien , Nigeria , Belarus , Niederlande , Norwegen , Neuseeland , Peru , Philippinen , Pakistan , Polen , Bulgarien , Rumänien , Russland , Aserbaidschan , Singapur , Thailand , Türkei , Taiwan , Ukraine , Österreich , Vietnam , Argentinien , Irland , Dominikanische Republik , Algerien , Ecuador , Spanien , Kolumbien , China , Griechenland , Sonderverwaltungsregion Hongkong , Ungarn , Indonesien , Malaysia , Israel , Vereinigte Arabische Emirate , Schweiz , Japan , Südkorea , Kuwait , Kasachstan , Libanon , Malta
- Zuletzt aktualisiert
- vor 3 Tagen
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.
- © 2024 AppTail.
- Unterstützung
- Privacy
- Terms
- All Apps